Seek Returns logo

ABT vs. MDGL: A Head-to-Head Stock Comparison

Updated

Here’s a clear look at ABT and MDGL, comparing key factors like performance, valuation metrics, dividends, and financial strength.

Company Overview

ABT’s market capitalization of 233.03 billion USD is substantially larger than MDGL’s 6.09 billion USD, indicating a significant difference in their market valuations.

ABT has a positive beta (0.74), indicating it generally moves with the broader market, whereas MDGL has a negative beta (-1.08), often moving inversely, which can offer diversification or hedging benefits.

SymbolABTMDGL
Company NameAbbott LaboratoriesMadrigal Pharmaceuticals, Inc.
CountryUSUS
SectorHealthcareHealthcare
IndustryMedical - DevicesBiotechnology
CEOMr. Robert B. FordMr. William J. Sibold
Price133.94 USD274.1 USD
Market Cap233.03 billion USD6.09 billion USD
Beta0.74-1.08
ExchangeNYSENASDAQ
IPO DateMarch 17, 1980February 6, 2007
ADRNoNo

Performance Comparison

This chart compares the performance of ABT and MDGL over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Data is adjusted for dividends and splits.

  • ABT: $12699.35 (26.99%)
  • MDGL: $11217.97 (12.18%)

Valuation Metrics Comparison

This section compares the market valuation of ABT and MDGL. Key takeaways regarding their valuation, when viewed within their industry context, are presented in the commentary that follows.

  • MDGL’s Price-to-Earnings (P/E) ratio of -15.46 is negative. This indicates the company is currently not generating profit, a key factor that can weigh on its stock valuation and investor sentiment.
  • MDGL’s Forward PEG ratio of -0.83 is negative. Such a figure commonly arises from negative earnings or forecasts of diminishing profitability, making standard valuation comparisons based on growth particularly challenging.
SymbolABTMDGL
Price-to-Earnings Ratio (P/E, TTM)17.33-15.46
Forward PEG Ratio (TTM)1.74-0.83
Price-to-Sales Ratio (P/S, TTM)5.5019.18
Price-to-Book Ratio (P/B, TTM)4.798.52
EV-to-EBITDA (TTM)21.41-16.01
EV-to-Sales (TTM)5.6618.97

Dividend Comparison

ABT provides a 1.70% dividend yield, potentially offering a blend of income and growth, whereas MDGL currently does not pay a dividend, possibly retaining profits to fund operations or growth initiatives.

SymbolABTMDGL
Dividend Yield (TTM)1.70%0.00%

Financial Strength Metrics Comparison

This section evaluates the financial strength of ABT and MDGL. Noteworthy observations on their financial resilience, considered from an industry perspective, are detailed in the points that follow.

  • MDGL’s Interest Coverage Ratio (ICR) of -30.09 is negative. This signals that its current operating earnings are insufficient to meet its interest obligations, a critical red flag for its financial health and capacity to manage its debt.
SymbolABTMDGL
Current Ratio (TTM)1.785.91
Quick Ratio (TTM)1.275.58
Debt-to-Equity Ratio (TTM)0.270.17
Debt-to-Asset Ratio (TTM)0.160.12
Net Debt-to-EBITDA Ratio (TTM)0.600.17
Interest Coverage Ratio (TTM)15.39-30.09